Real-world use of insulin degludec/liraglutide (IDegLira) significantly improves glycaemic control in patients with Type 2 diabetes

被引：0
|
作者：
Feher, M. [1 ]
Price, H. [2 ]
Schultes, B. [3 ]
Prager, R. [4 ]
Phan, T. M. [5 ]
Thorsted, B. L. [6 ]
Bluher, M. [7 ]
机构：
[1] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
[2] Southern Hlth NHS Fdn Trust, Bournemouth, Dorset, England
[3] ESwiss Med & Surg Ctr, Internal Med, St Gallen, Switzerland
[4] Hietzing Hosp, Dept Metab Disorders & Nephrol, Vienna, Austria
[5] Novo Nordisk Reg Europe Pharmaceut AS, Copenhagen, Denmark
[6] Novo Nordisk AS, Global Market Access, Soborg, Denmark
[7] Univ Leipzig, Dept Med, Leipzig, Germany
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P391
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [31] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Oya, Junko
    Nakagami, Tomoko
    Hasegawa, Yukiko
    Kondo, Yuichiro
    Katamine, Aki
    Shimizu, Mika
    Kubota, Ryo
    Suda, Rika
    Babazono, Tetsuya
    [J]. DIABETOLOGY INTERNATIONAL, 2024, 15 (02) : 237 - 243
  • [32] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Junko Oya
    Tomoko Nakagami
    Yukiko Hasegawa
    Yuichiro Kondo
    Aki Katamine
    Mika Shimizu
    Ryo Kubota
    Rika Suda
    Tetsuya Babazono
    [J]. Diabetology International, 2024, 15 : 237 - 243
  • [33] Improved postprandial glycaemic control in Type 2 diabetes with a combination of insulin degludec and liraglutide: results from a meal test
    Gough, S. C. L.
    Rodbard, H. W.
    Woo, V. C.
    Linjawi, S.
    Poulsen, P.
    Damgaard, L.
    Bode, B. W.
    [J]. DIABETIC MEDICINE, 2014, 31 : 61 - 61
  • [34] Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia
    Mussa H. AlMalki
    Hossam Aldesokey
    Dania Alkhafaji
    Abdulrahman Alsheikh
    Uffe Christian Braae
    Lars Lang Lehrskov
    Waleed Magawry
    Moataz Yahia
    Ahmed Haroun
    [J]. Advances in Therapy, 2023, 40 : 568 - 584
  • [35] VIEW-Iran: A real-world study of liraglutide effectiveness on glycaemic control in people with type 2 diabetes mellitus
    Khamseh, M. E.
    Hosseinpanah, F.
    Malek, M.
    Damavandi, M. H.
    Thamattoor, U. K.
    Kaltoft, M. S.
    Esteghamati, A.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [36] Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real-world clinical evidence
    Mezquita Raya, Pedro
    Ampudia Blasco, Francisco Javier
    Hunt, Barnaby
    Martin, Virginia
    Larsen Thorsted, Brian
    Basse, Amaury
    Price, Hermione
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1349 - 1356
  • [37] A novel fixed-ratio combination of insulin degludec and liraglutide improves postprandial glycaemic control in patients with type 2 diabetes: results from a standardised meal test
    Holst, J. J.
    Buse, J.
    Gough, S. C. L.
    Rodbard, H. W.
    Woo, V. C.
    Linjawi, S.
    Poulsen, P.
    Damgaard, L. H.
    Bode, B. W.
    [J]. DIABETOLOGIA, 2013, 56 : S359 - S359
  • [38] An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin
    Evans, Marc
    Billings, Liana K.
    Hakan-Bloch, Jonas
    Slothuus, Ulla
    Abrahamsen, Trine J.
    Andersen, Andreas
    Jansen, Jeroen P.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (04) : 340 - 347
  • [39] Switching to Insulin Degludec Improves Glycemic Control in Patients with T2DM in a Real-World Setting
    Schultes, Bernd
    Tentolouris, Nikolaos
    Knudsen, Soren T.
    Lapolla, Annunziata
    Eidenmueller, Markus
    Prager, Rudolf
    Phan, Tra-Mi
    Wolden, Michael L.
    Siegmund, Thorsten
    [J]. DIABETES, 2017, 66 : A266 - A266
  • [40] Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
    Minze, Molly G.
    Chastain, Lisa M.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 471 - 478
12345